Jonathan Weinsaft, MD, Cardiology, New York, NY, New York-Presbyterian Hospital

JonathanW.WeinsaftMD

Cardiology New York, NY

Adult Congenital Heart Disease

Associate Professor, Medicine, Weill Cornell Medical College

Dr. Weinsaft is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Weinsaft's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital
    New York Presbyterian HospitalFellowship, Cardiovascular Disease, 2000 - 2003
  • New York Presbyterian Hospital
    New York Presbyterian HospitalResidency, Internal Medicine, 1997 - 2000
  • NYU School of Medicine
    NYU School of MedicineClass of 1997

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2003 - 2006
  • NY State Medical License
    NY State Medical License 1998 - 2022
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clinical Quantitative Susceptibility Mapping (QSM): Biometal Imaging and Its Emerging Roles in Patient Care  
    Gary M Brittenham, Apostolos John Tsiouris, Lawrence Tanenbaum, Ajay Gupta, Martin R Prince, Jonathan W Weinsaft, Susan A Gauthier, Brian H Kopell, Michael G Kaplitt, ..., Journal of Magnetic Resonance Imaging

Lectures

  • Hypertrophic & Restrictive Cardiomyopathy: Genetics, Imaging and Emerging Treatments in Adult and Pediatric Patients 
    Columbia University, Department of Surgery, New York, New York - 3/13/2013

Authored Content

  • More Than Meets the Eye: Time for a New Imaging Paradigm to Test for Cardiac AmyloidosisJanuary 2018
  • More Than Meets the Eye: Time for a New Imaging Paradigm to Test for Cardiac AmyloidosisJanuary 2018

Press Mentions

  • Damage to Heart's Right Ventricle Predicts a Greater Chance of Death from COVID-19
    Damage to Heart's Right Ventricle Predicts a Greater Chance of Death from COVID-19October 26th, 2020
  • Appropriate Use Criteria
    Appropriate Use CriteriaMarch 1st, 2019

Grant Support

  • Delayed Enhancement MRI For Detection Of Sub-Clinical Papillary Muscle InfarctionNational Heart, Lung, And Blood Institute2010–2011

Professional Memberships

Hospital Affiliations